Azithromycin vs Nivolumab

Azithromycin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Azithromycin and Nivolumab.

Mechanism of Action

Azithromycin: Binds 50S ribosomal subunit, inhibiting bacterial protein synthesis.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Azithromycin — 68 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Azithromycin — C38H72N2O12.

Molecular Weight: Azithromycin — 748.9840 g/mol.

Type: Azithromycin — Small molecule; Nivolumab — Antibody.